O
IMTX icon

OrbiMed’s Immatics IMTX Stock Holding History

OrbiMed’s Portfolio IMTX Stock Details IMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-466,601
Closed -$3.98M – 116
2025
Q3 		$3.98M Sell
466,601
-253,300
-35% -$1.56M 0.09% 93
2025
Q2 		$3.87M Sell
719,901
-2,367,561
-77% -$11.7M 0.1% 82
2025
Q1 		$13.9M Hold
3,087,462
– – 0.33% 53
2024
Q4 		$22M Buy
3,087,462
+1,081,081
+54% +$9.29M 0.45% 50
2024
Q3 		$22.9M Hold
2,006,381
– – 0.42% 59
2024
Q2 		$23.3M Buy
2,006,381
+236,673
+13% +$2.67M 0.46% 56
2024
Q1 		$18.6M Buy
1,769,708
+226,301
+15% +$2.64M 0.34% 68
2023
Q4 		$16.3M Buy
1,543,407
+493,207
+47% +$4.54M 0.32% 67
2023
Q3 		$12.2M Buy
1,050,200
+83,371
+9% +$995K 0.26% 76
2023
Q2 		$11.2M Buy
966,829
+19,581
+2% +$183K 0.2% 85
2023
Q1 		$6.54M Buy
+947,248
New +$7.75M 0.13% 96

Other funds holding IMTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

OrbiMed's IMTX Position: Q4 2025 in Review

OrbiMed sold out of Immatics (IMTX) in Q4 2025, closing a stake of 466,601 shares — an estimated $3.98M sold.

OrbiMed first reported a position in IMTX in Q1 2023 and held it in 11 quarters. The position peaked at $23.3M in Q2 2024. 75 funds tracked by Wall St. Rank hold IMTX as of Q4 2025.

  • OrbiMed reported no remaining Immatics position as of Q4 2025 after selling out during the quarter.
  • OrbiMed sold 466,601 Immatics shares in Q4 2025, an estimated $3.98M.
  • OrbiMed first reported a position in Immatics in Q1 2023 and held it in 11 quarters.
  • OrbiMed's Immatics position peaked at $23.3M in Q2 2024.
  • 75 funds tracked by Wall St. Rank held Immatics as of Q4 2025.

Based on OrbiMed's 13F filing for Q4 2025, filed 17 Feb 2026.